[A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). 3. Toxicological and pharmacological study].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000633:toxicity*; D001158:Arteries; D001769:Blood / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002642:Chick Embryo; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013094:Spermatozoa / Q000187:drug effects; D013737:Testis / Q000187:drug effects
D000903:Antibiotics, Antineoplastic
Un nouvel antibiotique doué d'activité antitumorale: la rubidomycine (13.057 R.P.). 3: Etude toxicologique et pharmacologique.